EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19

Aditya Kasarabada, Kimberly Barker, Theresa Ganoe, Lindsay Clevenger, Cristina Visco, Jessica Gibson, Rahim Karimi, Negar Naderi, Brian Lam, Maria Stepanova, Linda Henry iD, Christopher King iD und 1 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Aditya Kasarabada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Critical Care Service, Inova Fairfax Hospital, Falls Church, Virginia, United States of America. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, Type 2, Obesity, Morbid, Noninvasive Ventilation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim We investigated the association of noninvasive oxygenation support [high flow nasal cannula (HFNC) and BiPAP], timing of invasive mechanical ventilation (IMV), and inpatient mortality among patients hospitalized with COVID-19.

Methods

Retrospective chart review study of patients hospitalized with COVID-19 (ICD-10 code U07.1) and received IMV from March 2020-October 2021. Charlson comorbidity index (CCI) was calculated; Obesity defined as body mass index (BMI) ≥ 30 kg/m 2 ; morbid obesity was BMI ≥ 40 kg/m 2 . Clinical parameters/vital signs recorded at time of admission.

Results

709 COVID-19 patients underwent IMV, predominantly admitted from March-May 2020 (45%), average age 62±15 years, 67% male, 37% Hispanic, and 9% from group living settings. 44% had obesity, 11% had morbid obesity, 55% had type II diabetes, 75% had hypertension, and average CCI was 3.65 (SD = 3.11). Crude mortality rate was 56%. Close linear association of age with inpatient-mortality risk was found [OR (95% CI) = 1.35 (1.27–1.44) per 5 years, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes Mellitus, Type 2Obesity, MorbidNoninvasive VentilationRespiratory InsufficiencyHumansMaleMiddle AgedAgedInfant, NewbornChild, PreschoolFemaleRetrospective StudiesRespiration, ArtificialCannulaOxygen Inhalation Therapy

Autor:innen und Institutionen

  • Medical Critical Care Service, Inova Fairfax Hospital, Falls Church, Virginia, United States of America.
  • Medicine Service Line, Inova Health Systems, Falls Church, Virginia, United States of America.
  • Department of Advanced Lung Disease and Transplant, Inova Fairfax Hospital, Falls Church, Virginia, United States of America.

ORCID-Profile: Linda Henry, Christopher King

Zitieren

APA

Kasarabada, A., Barker, K., Ganoe, T., Clevenger, L., Visco, C., Gibson, J., Karimi, R., Naderi, N., Lam, B., Stepanova, M., Henry, L., King, C., & Desai, M. (2023). How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19. PLOS ONE. https://doi.org/10.1371/journal.pone.0281859

Vancouver

Kasarabada A, Barker K, Ganoe T, Clevenger L, Visco C, Gibson J, et al. How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19. PLOS ONE. 2023. doi:10.1371/journal.pone.0281859

BibTeX
@article{Kasarabada2023,
  author = {Kasarabada, Aditya and Barker, Kimberly and Ganoe, Theresa and Clevenger, Lindsay and Visco, Cristina and Gibson, Jessica and Karimi, Rahim and Naderi, Negar and Lam, Brian and Stepanova, Maria and Henry, Linda and King, Christopher and Desai, Mehul},
  title = {How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281859}
}
Kostenlos starten →